Today is the first full day of fall, which is also the typical beginning of cold and flu season, and potentially COVID resurgence season.
The biggest news this week is the authorization and distribution of the new “bivalent” vaccine for COVID-19.
The FDA formally authorized (EUA) updated COVID-19 boosters this week. We recommend that anyone who is eligible for this booster should get it.
While still a little too soon to say Monkeypox is on its way out, the peak in cases appears to have occurred about 3 weeks ago
Globally, there are about 38,000 cases of Monkeypox, in Europe there are roughly 19,000 cases and in the US there are nearly 13,000.
It is important to keep a couple of comparisons between COVID and Monkeypox in mind as you process the news about Monkeypox.
Case counts remain relatively flat in US, although there may be indications of beginning of a slight downward trend.
While there continues to be COVID news, over the last week, the media has been less focused on COVID and much more focused on Monkeypox.
What is driving most increases and keeping a floor under decreases is omicron BA4/BA5 and of those two, primarily BA5.
COVID is not going away easily. Omicron sub-variants BA4 and BA5 are rapidly replacing BA2 and BA 2.12.1 in much of the world.